Stock listing

NYSE:MYOV Myovant Sciences Ltd Stock

Follow Myovant Sciences Ltd into a list and get an email when it puts out news.

Last close · NYSE:MYOV

$26.98 USD

Close on Mar 9, 2023 · No longer trades

Oct 27, 2016 to last close +103.5% · weekly closes, Oct 27, 2016 – Mar 9, 2023
Lowest – highest close
$4.20 – $27.62 USDSince Oct 27, 2016 · lowest Oct 28, 2019 · highest Dec 31, 2020

Delisted NYSE:MYOV no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NYSE:MYOV
Asset type
Stock
Exchange
NYSE
Currency
USD

Myovant Sciences Ltd on 6ix

Decks
1 deck · latest May 14, 2019

Decks

DeckKindSlidesDate
Technical Presentation (May 2019)Technical21 slidesMay 14, 2019

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Myrtle S Potter
Other companies: Ginkgo Bioworks Holdings, Inc. (Director · Since at least Jun 13, 2024); Guardant Health, Inc. (Director · Since at least Oct 15, 2021); Immunovant, Inc. (Director · Dec 18, 2019 – Dec 18, 2019 · Past); Arbutus Biopharma Corporation (Director · Oct 18, 2018 – Aug 17, 2019 · Past); Sio Gene Therapies Inc (Director · Sep 26, 2018 – Apr 15, 2019 · Past); Urovant Sciences Ltd (Director · Sep 26, 2018 – Mar 29, 2021 · Past); Axsome Therapeutics, Inc. (Director · Jun 16, 2017 – Jun 7, 2019 · Past); Insmed Incorporated (Director · Dec 11, 2014 – May 15, 2018 · Past); Everyday Health Inc (Director · Mar 27, 2014 – Dec 3, 2016 · Past); Rite Aid Corporation (Director · Nov 29, 2013 – Oct 3, 2017 · Past)
Director · Sep 20, 2018 – Mar 10, 2023 · Past
Lynn Seely
Other companies: AbCellera Biologics Inc. (Director · Since at least Jun 30, 2026); Lyell Immunopharma, Inc. (President and CEO, Director · Since at least Jun 16, 2021); Blueprint Medicines Corp (Director · Since at least Jun 19, 2019)
Principal Executive Officer, Director · Apr 5, 2019 – Apr 3, 2020 · Past
Matthew Lang
Other companies: Structure Therapeutics, Inc. (COO & GC · Since at least Apr 15, 2026); Metsera, Inc. (CHIEF LEGAL OFFICER · Since at least Apr 28, 2025); Lyell Immunopharma, Inc. (Chief Business Officer · Jul 1, 2023 – Feb 10, 2025 · Past)
General Counsel & Corp. Secy. · Apr 5, 2019 – Mar 10, 2023 · Past
Kim Sablich
Other companies: Eiger Biopharmaceuticals Inc (Director · Apr 23, 2021 – Mar 1, 2023 · Past); Jazz Pharmaceuticals plc (EVP, GM of U.S. · Jun 1, 2020 – Jun 5, 2023 · Past)
Chief Commercial Officer · Dec 1, 2018 – Apr 3, 2020 · Past
Mark Altmeyer
Other companies: Alector, Inc. (Board Member · Since at least Mar 19, 2024); Sio Gene Therapies Inc (Pres (ASG) & Chief Comm. Ofc. · Jun 10, 2015 – Mar 15, 2018 · Past)
Director · Oct 26, 2016 – Aug 31, 2018 · Past
Marianne L Romeo
Other companies: Sio Gene Therapies Inc (Head,Global Trans & Risk Mgmt, Director · Apr 29, 2016 – Apr 29, 2016 · Past)
Head,Global Trans. & Risk Mgmt · Oct 26, 2016 – Oct 26, 2016 · Past

Open People

Log in to ask 6ix AI your own questions about Myovant Sciences Ltd.